Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar Gonzalez

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Biorxiv : the Preprint Server for Biology|October 28, 2024
Intratumoral CXCL12 Gradients Contextualize Tumor Cell Invasion, Migration and Immune Suppression in Breast CancerDimitra P Anastasiadou, Nicole Couturier, Sakshi Goel, et al.
Communications Medicine|June 12, 2023
Proteomic characterization of acute kidney injury in patients hospitalized with SARS-CoV2 infectionIshan Paranjpe, Pushkala Jayaraman, Chen-Yang Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2024
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I TrialEdwin Roger Parra, Jiexin Zhang, Dzifa Yawa Duose, et al.
Nature Medicine|June 15, 2023
Intratumoral dendritic cell-CD4<sup>+</sup> T helper cell niches enable CD8<sup>+</sup> T cell differentiation following PD-1 blockade in hepatocellular carcinomaAssaf Magen, Pauline Hamon, Nathalie Fiaschi, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancerRaphaël Mattiuz, Jesse Boumelha, Pauline Hamon, et al.
Neuro-Oncology|March 22, 2025
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastomaPatrick Y Wen, Andrea Manzanera, Caroline Duault, et al.
Clinical Proteomics|September 28, 2022
The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individualsGuillaume Butler-Laporte, Edgar Gonzalez-Kozlova, Chen-Yang Su, et al.
Nature Medicine|January 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockadeEdgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo, et al.
Clinical Proteomics|November 15, 2022
Correction: The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individualsGuillaume Butler-Laporte, Edgar Gonzalez-Kozlova, Chen-Yang Su, et al.
Scientific Reports|April 17, 2023
Circulating proteins to predict COVID-19 severityChen-Yang Su, Sirui Zhou, Edgar Gonzalez-Kozlova, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Biorxiv : the Preprint Server for Biology|October 28, 2024
Intratumoral CXCL12 Gradients Contextualize Tumor Cell Invasion, Migration and Immune Suppression in Breast CancerDimitra P Anastasiadou, Nicole Couturier, Sakshi Goel, et al.
Communications Medicine|June 12, 2023
Proteomic characterization of acute kidney injury in patients hospitalized with SARS-CoV2 infectionIshan Paranjpe, Pushkala Jayaraman, Chen-Yang Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2024
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I TrialEdwin Roger Parra, Jiexin Zhang, Dzifa Yawa Duose, et al.
Nature Medicine|June 15, 2023
Intratumoral dendritic cell-CD4<sup>+</sup> T helper cell niches enable CD8<sup>+</sup> T cell differentiation following PD-1 blockade in hepatocellular carcinomaAssaf Magen, Pauline Hamon, Nathalie Fiaschi, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancerRaphaël Mattiuz, Jesse Boumelha, Pauline Hamon, et al.
Neuro-Oncology|March 22, 2025
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastomaPatrick Y Wen, Andrea Manzanera, Caroline Duault, et al.
Clinical Proteomics|September 28, 2022
The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individualsGuillaume Butler-Laporte, Edgar Gonzalez-Kozlova, Chen-Yang Su, et al.
Nature Medicine|January 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockadeEdgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo, et al.
Clinical Proteomics|November 15, 2022
Correction: The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individualsGuillaume Butler-Laporte, Edgar Gonzalez-Kozlova, Chen-Yang Su, et al.
Scientific Reports|April 17, 2023
Circulating proteins to predict COVID-19 severityChen-Yang Su, Sirui Zhou, Edgar Gonzalez-Kozlova, et al.
Pageof 11